CJC-1295/Ipamorelin

Description

CJC-1295 (No DAC) and Ipamorelin are synthetic peptides commonly studied together in laboratory research focused on growth hormone signaling pathways. CJC-1295 functions as a modified growth hormone–releasing hormone (GHRH) analog, while Ipamorelin is a selective ghrelin receptor agonist that may stimulate growth hormone release through a different biological pathway.

Laboratory studies have examined how these peptides interact within endocrine signaling systems when used together in experimental models. Researchers continue to explore the potential influence of this peptide combination on pathways associated with metabolic regulation, recovery processes, and lean tissue development in controlled research environments.

Specifications

• Lyophilized research peptide blend
• Contains 5mg CJC-1295 (No DAC) and 5mg Ipamorelin
• High purity material
• Laboratory-grade preparation
• Sealed sterile vial

Research Use Only

This product is supplied strictly for laboratory research purposes.

This material is not intended for human consumption, medical use, diagnostic use, or therapeutic application.